Linda C. Bain

Chief Financial Officer

Linda Bain joined Codiak from Avalanche Biotechnologies where, as Chief Financial Officer, she led a successful IPO and follow-on financing. She previously served as Vice President of Finance, Business Operations and Treasurer at bluebird bio, where her tenure included a Series D financing and IPO.

Ms. Bain has held senior roles at Genzyme Corporation, including Vice President of Finance, Global Manufacturing and Operations and Vice President of Finance of Genzyme Genetics, where she was a member of the team that divested the business unit to LabCorp for $925 million.

Earlier in her career, she served in senior finance roles at Fidelity Investments and AstraZeneca Pharmaceuticals and as an auditor at Deloitte & Touche. Ms. Bain is a member of the board of directors for Autolus Therapeutics.